{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:04:36Z","timestamp":1781327076339,"version":"3.54.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD) is a serious, long-term illness that damages kidneys and lowers glomerular filtration rate. CKD often causes anemia. Iron deficiency (ID) is common in these patients and worsens illness symptoms. Modern hematology analysers can measure reticulocyte mean cell hemoglobin (MCHr), which directly measures iron integration into erythrocyte hemoglobin. MCHr can improve iron deficiency detection in CKD patients, who have aberrant iron indicators due to chronic inflammation. This research aims to evaluate the effectiveness of MCHr as a marker for ID in patients with CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      To obtain data for this study, CBC, reticulocyte profile, and iron biomarkers were collected from King Khalid National Guard Hospital (Ref No. IRB\/1861\/23). Transferring saturation was calculated using (Serum iron\/TIBC) \u00d7 100. GraphPad Prism 9 software was used to analyze the data, and Mann-Whitney, Spearman correlation, and ROC plots were used to determine MCHr's diagnostic performance. A\n                      <jats:italic>p<\/jats:italic>\n                      -\n                      <jats:italic>value<\/jats:italic>\n                      &amp;lt; 0.05 was considered significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>The study compared 190 individuals undergoing hemodialysis (HD) with 165 healthy blood donors. The HD group showed lower levels of RBC, Hb, MCHr, serum iron, and total iron-binding capacity (TIBC). Despite anemia, the HD group had higher levels of ferritin and transferrin saturation (TSAT). MCHr demonstrated excellent diagnostic performance in identifying iron deficiency anemia (IDA), particularly in functional iron deficiency. When TSAT was &amp;lt; 20%, MCHr showed an AUC of 0.98, with 100% specificity and 72.41% sensitivity, significantly outperforming ferritin and TSAT in inflammatory settings. In the HD group with ferritin levels &amp;lt; 200 ng\/mL, the MCHr cut-off value of &amp;lt; 31.20 pg had a sensitivity and specificity of 89.47% and an AUC of 0.89. When TSAT was &amp;lt; 20%, the MCHr cut-off value of &amp;lt; 23.95 pg had a sensitivity of 72.41%, specificity of 100%, and AUC of 0.98.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Based on the findings, MCHr is more effective than ferritin and TSAT in detecting iron deficiency in hemodialysis patients. Future research should use MCH to investigate the impact of iron therapy with or without rHuEPO.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1689529","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:47:54Z","timestamp":1762429674000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic utility of reticulocyte hemoglobin for iron-restricted anemia in patients with end-stage kidney disease on hemodialysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Majed N.","family":"Almashjary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar M.","family":"Sahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohannad S.","family":"Hazzazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad H.","family":"Alhashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed M.","family":"Bawazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar A.","family":"Basabrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Borai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitham","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Almohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik A.","family":"Altayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah M.","family":"Alqarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahl A.","family":"Jamalallail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salem M.","family":"Bahashwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Qanash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elrashed B.","family":"Yasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","article-title":"Chronic kidney disease","volume":"379","author":"Levey","year":"2012","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease\u2013a systematic review and meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS ONE."},{"key":"B3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/kisup.2012.45","article-title":"KDIGO clinical practice guideline for anemia in chronic kidney disease","volume":"2","author":"A\u043d\u0435\u043c\u0456\u0457","year":"2012","journal-title":"Kidney Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.23937\/2377-3634\/141010","article-title":"Comorbidity among patients with kidney diseases in Hail Region, Saudi Arabia","volume":"6","author":"Ansari","year":"2019","journal-title":"Int J Diabetes Clin Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e84943","DOI":"10.1371\/journal.pone.0084943","article-title":"Prevalence of anemia in chronic kidney disease in the United States","volume":"9","author":"Stauffer","year":"2014","journal-title":"PLoS ONE."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1001\/archinte.162.12.1401","article-title":"Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994)","volume":"162","author":"Astor","year":"2002","journal-title":"Arch Intern Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.4103\/1319-2442.308335","article-title":"Diagnosis of iron deficiency in hemodialysis patients: usefulness of measuring reticulocyte hemoglobin equivalent","volume":"31","author":"Sany","year":"2020","journal-title":"Saudi J Kidney Dis Transpl."},{"key":"B8","volume-title":"Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity.","year":"2011"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"New Engl J Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"12311","DOI":"10.1111\/bjh.12311","article-title":"Guideline for the laboratory diagnosis of functional iron deficiency","volume":"161","author":"Thomas","year":"2013","journal-title":"Br J Haematol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2257.2006.00812.x","article-title":"Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states","volume":"28","author":"Brugnara","year":"2006","journal-title":"Clin Lab Haematol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1093\/clinchem\/48.7.1066","article-title":"Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency","volume":"48","author":"Thomas","year":"2002","journal-title":"Clin Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1053\/j.ajkd.2017.09.026","article-title":"Update on anemia in ESRD and earlier stages of CKD: core curriculum 2018","volume":"71","author":"Fishbane","year":"2018","journal-title":"Am J Kidney Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1751-553X.2009.01179.x","article-title":"Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency","volume":"32","author":"Miwa","year":"2010","journal-title":"Int J Lab Hematol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s12288-021-01464-3","article-title":"evaluation of iron status by reticulocyte haemoglobin content (Chr) in chronic kidney disease patients on haemodialysis and erythropoietin","volume":"38","author":"Karunarathne","year":"2022","journal-title":"Indian J Hematol Blood Transfus."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.3390\/jcm11195675","article-title":"Reticulocyte hemoglobin-equivalent potentially detects, diagnoses and discriminates between stages of iron deficiency with high sensitivity and specificity","volume":"11","author":"Almashjary","year":"2022","journal-title":"J Clin Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/ajh.24820","article-title":"Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management","volume":"92","author":"Cappellini","year":"2017","journal-title":"Am J Hematol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1038\/ki.1996.487","article-title":"randomized controlled study of iron supplementation in patients treated with erythropoietin","volume":"50","author":"Macdougall","year":"1996","journal-title":"Kidney Int."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1172\/JCI20945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J Clin Invest."},{"key":"B21","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1053\/j.ajkd.2008.12.040","article-title":"Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients","volume":"53","author":"Kalantar-Zadeh","year":"2009","journal-title":"Am J Kidney Diseases."},{"key":"B22","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1681\/ASN.V113530","article-title":"Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients","volume":"11","author":"Besarab","year":"2000","journal-title":"J Am Soc Nephrol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/ki.2008.295","article-title":"Secondary analysis of the CHOIR trial epoetin-\u03b1 dose and achieved hemoglobin outcomes","volume":"74","author":"Szczech","year":"2008","journal-title":"Kidney Int."},{"key":"B24","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1053\/j.ajkd.2006.03.011","article-title":"KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease","volume":"47","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1093\/ndt\/gfq336","article-title":"Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to Reduce Cardiovascular Events with Aranesp\u00ae Therapy (TREAT) Study","volume":"25","author":"Locatelli","year":"2010","journal-title":"Nephrol Dial Transpl."},{"key":"B26","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10157-009-0235-x","article-title":"Preface: evidence-based practice guideline for the treatment of chronic kidney disease","volume":"13","author":"Sasaki","year":"2009","journal-title":"Clin Exp Nephrol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/ndt\/18.2.370","article-title":"Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients","volume":"18","author":"Chuang","year":"2003","journal-title":"Nephrol Dial Transplant."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1689529\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:47:54Z","timestamp":1762429674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1689529\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":27,"alternative-id":["10.3389\/fmed.2025.1689529"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1689529","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"article-number":"1689529"}}